The requested item 00939 is obsolete and has been replaced. The new item is 01639.
5-LOX Inhibitor with AprèsFlex™ 100 mg, 60 vegetarian capsules Item Catalog Number: 01639 |
|

Excess levels of the enzyme 5-lipoxygenase or 5-LOX sets in motion inflammatory responses that has been linked to common degenerative effects in aging individuals.1-5 Normal aging results in higher-than-desired levels of 5-LOX.
The typical American diet adds to the danger. Foods rich in omega-6 fatty acids like red meat, poultry, eggs and dairy products, along with high-glycemic carbohydrates, trigger overproduction of arachidonic acid. In response to high levels of arachidonic acid, the body produces the 5-LOX enzyme.
5-LOX breaks down arachidonic acid to pro-inflammatory compounds like leukotriene B4,6 a molecule that attacks joints, arterial walls, and other tissues. 5-LOX itself facilitates undesirable cell division changes.
The good news is that extract of the Indian plant Boswellia serrata has been shown to neutralize 5-LOX. Used for centuries to help with inflammatory issues, boswellia acts a natural 5-LOX inhibitor, intervening at the cellular level to block its unwanted effects. Confirmatory data reveal that a compound contained in boswellia called AKBA (3-O-acetyl-11-keto-ß-boswellic acid)7,8 is the key to its beneficial action. The problem is that boswellia is not readily absorbed into the blood.9
For this reason, a patent-pending, standardized form of boswellia called AprèsFlex™ is being introduced that absorbs into the blood 52% more than previously available boswellia extracts.9 Each 100 mg vegetarian capsule of 5-LOX Inhibitor with AprèsFlex™ is standardized to provide 20% of active AKBA from boswellia. Most people need only one capsule a day. |
References 1. Neurobiol Aging. 2007 Sep;28(9):1457-62. 2. Cardiovasc Psychiatry Neurol. 2009;2009:174657. 3. Free Radic Biol Med. 2009 Jul 1;47(1):62-71. 4. Rejuvenation Res. 2009 Feb;12(1):15-24. 5. Available at: http://www.cdc.gov/nchs/fastats/lcod.htm. Accessed July 29, 2011. 6. Curr Opin Investig Drugs. 2009 Nov;10(11):1163-72. 7. Wien Med Wochenschr. 2002;152(15-16):373-8. 8. J Ethnopharmacol. 2006 Sep 19;107(2):249-53. 9. Mol Cell Biochem. 2011 Aug;354(1-2):189-97. |
| Supplement Facts |
|
Serving Size 1 vegetarian capsule |
|
Servings Per Container 60 |
| Amount Per Serving |
|
AprèsFlex™ (Boswellia serrata) extract (gum resin) [std. to 20% 3-O-acetyl-11-keto-ß-boswellic acid (AKBA) (20 mg)] |
100 mg |
|
Other ingredients: microcrystalline cellulose, vegetable cellulose (capsule), silica, vegetable stearate. |
AprèsFlex™ is a trademark of Laila Nutraceuticals exclusively licensed to PL Thomas – Laila Nutra LLC. International patents pending. |
| Dosage and Use |
|
To inhibit the 5-lipoxygenase enzyme, take one capsule daily with or without food, or as recommended by a healthcare practitioner. | |
| Note |
| Not available for sale to Food and Drug Stores. | |
| Warnings |
|